Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-17

Clinical Trial Update: An Observational Study to Assess the Quality of Life of the Patients With Multiple Sclerosis and Their Caregivers

View source ↗

Summary

An observational study evaluating the quality of life of patients with multiple sclerosis and their caregivers has completed. Sponsor: Merck KGaA, Darmstadt, Ge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Multiple Sclerosis | Status: COMPLETED